- IBDEI2VD ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,45773,1,4,0)
- ;;=4^F17.221
- ;;^UTILITY(U,$J,358.3,45773,2)
- ;;=^5003371
- ;;^UTILITY(U,$J,358.3,45774,0)
- ;;=F17.223^^172^2281^3
- ;;^UTILITY(U,$J,358.3,45774,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45774,1,3,0)
- ;;=3^Nicotine Dependence,Chewing Tobacco w/ Withdrawal
- ;;^UTILITY(U,$J,358.3,45774,1,4,0)
- ;;=4^F17.223
- ;;^UTILITY(U,$J,358.3,45774,2)
- ;;=^5003372
- ;;^UTILITY(U,$J,358.3,45775,0)
- ;;=F17.228^^172^2281^4
- ;;^UTILITY(U,$J,358.3,45775,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45775,1,3,0)
- ;;=3^Nicotine Dependence,Chewing Tobacco w/ Oth Disorders
- ;;^UTILITY(U,$J,358.3,45775,1,4,0)
- ;;=4^F17.228
- ;;^UTILITY(U,$J,358.3,45775,2)
- ;;=^5003373
- ;;^UTILITY(U,$J,358.3,45776,0)
- ;;=Z51.81^^172^2282^19
- ;;^UTILITY(U,$J,358.3,45776,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45776,1,3,0)
- ;;=3^Therapeutic Drug Monitoring
- ;;^UTILITY(U,$J,358.3,45776,1,4,0)
- ;;=4^Z51.81
- ;;^UTILITY(U,$J,358.3,45776,2)
- ;;=^5063064
- ;;^UTILITY(U,$J,358.3,45777,0)
- ;;=Z79.01^^172^2282^6
- ;;^UTILITY(U,$J,358.3,45777,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45777,1,3,0)
- ;;=3^Long Term Current Use of Anticoagulants
- ;;^UTILITY(U,$J,358.3,45777,1,4,0)
- ;;=4^Z79.01
- ;;^UTILITY(U,$J,358.3,45777,2)
- ;;=^5063330
- ;;^UTILITY(U,$J,358.3,45778,0)
- ;;=Z79.02^^172^2282^7
- ;;^UTILITY(U,$J,358.3,45778,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45778,1,3,0)
- ;;=3^Long Term Current Use of Antithrombotics/Antiplatelets
- ;;^UTILITY(U,$J,358.3,45778,1,4,0)
- ;;=4^Z79.02
- ;;^UTILITY(U,$J,358.3,45778,2)
- ;;=^5063331
- ;;^UTILITY(U,$J,358.3,45779,0)
- ;;=Z79.1^^172^2282^10
- ;;^UTILITY(U,$J,358.3,45779,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45779,1,3,0)
- ;;=3^Long Term Current Use of NSAIDs
- ;;^UTILITY(U,$J,358.3,45779,1,4,0)
- ;;=4^Z79.1
- ;;^UTILITY(U,$J,358.3,45779,2)
- ;;=^5063332
- ;;^UTILITY(U,$J,358.3,45780,0)
- ;;=Z79.2^^172^2282^5
- ;;^UTILITY(U,$J,358.3,45780,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45780,1,3,0)
- ;;=3^Long Term Current Use of Antibiotics
- ;;^UTILITY(U,$J,358.3,45780,1,4,0)
- ;;=4^Z79.2
- ;;^UTILITY(U,$J,358.3,45780,2)
- ;;=^321546
- ;;^UTILITY(U,$J,358.3,45781,0)
- ;;=Z79.82^^172^2282^8
- ;;^UTILITY(U,$J,358.3,45781,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45781,1,3,0)
- ;;=3^Long Term Current Use of Aspirin
- ;;^UTILITY(U,$J,358.3,45781,1,4,0)
- ;;=4^Z79.82
- ;;^UTILITY(U,$J,358.3,45781,2)
- ;;=^5063340
- ;;^UTILITY(U,$J,358.3,45782,0)
- ;;=Z79.51^^172^2282^9
- ;;^UTILITY(U,$J,358.3,45782,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45782,1,3,0)
- ;;=3^Long Term Current Use of Inhaled Steroids
- ;;^UTILITY(U,$J,358.3,45782,1,4,0)
- ;;=4^Z79.51
- ;;^UTILITY(U,$J,358.3,45782,2)
- ;;=^5063335
- ;;^UTILITY(U,$J,358.3,45783,0)
- ;;=Z79.52^^172^2282^11
- ;;^UTILITY(U,$J,358.3,45783,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45783,1,3,0)
- ;;=3^Long Term Current Use of Systemic Steroids
- ;;^UTILITY(U,$J,358.3,45783,1,4,0)
- ;;=4^Z79.52
- ;;^UTILITY(U,$J,358.3,45783,2)
- ;;=^5063336
- ;;^UTILITY(U,$J,358.3,45784,0)
- ;;=Z91.19^^172^2282^12
- ;;^UTILITY(U,$J,358.3,45784,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45784,1,3,0)
- ;;=3^Non-Compliance w/ Treatment/Regimen
- ;;^UTILITY(U,$J,358.3,45784,1,4,0)
- ;;=4^Z91.19
- ;;^UTILITY(U,$J,358.3,45784,2)
- ;;=^5063618
- ;;^UTILITY(U,$J,358.3,45785,0)
- ;;=Z87.01^^172^2282^15
- ;;^UTILITY(U,$J,358.3,45785,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,45785,1,3,0)
- ;;=3^Personal Hx of Pneumonia,Recurrent
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2VD 3781 printed Mar 13, 2025@21:41:26 Page 2
- IBDEI2VD ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,45773,1,4,0)
- +2 ;;=4^F17.221
- +3 ;;^UTILITY(U,$J,358.3,45773,2)
- +4 ;;=^5003371
- +5 ;;^UTILITY(U,$J,358.3,45774,0)
- +6 ;;=F17.223^^172^2281^3
- +7 ;;^UTILITY(U,$J,358.3,45774,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,45774,1,3,0)
- +10 ;;=3^Nicotine Dependence,Chewing Tobacco w/ Withdrawal
- +11 ;;^UTILITY(U,$J,358.3,45774,1,4,0)
- +12 ;;=4^F17.223
- +13 ;;^UTILITY(U,$J,358.3,45774,2)
- +14 ;;=^5003372
- +15 ;;^UTILITY(U,$J,358.3,45775,0)
- +16 ;;=F17.228^^172^2281^4
- +17 ;;^UTILITY(U,$J,358.3,45775,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,45775,1,3,0)
- +20 ;;=3^Nicotine Dependence,Chewing Tobacco w/ Oth Disorders
- +21 ;;^UTILITY(U,$J,358.3,45775,1,4,0)
- +22 ;;=4^F17.228
- +23 ;;^UTILITY(U,$J,358.3,45775,2)
- +24 ;;=^5003373
- +25 ;;^UTILITY(U,$J,358.3,45776,0)
- +26 ;;=Z51.81^^172^2282^19
- +27 ;;^UTILITY(U,$J,358.3,45776,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,45776,1,3,0)
- +30 ;;=3^Therapeutic Drug Monitoring
- +31 ;;^UTILITY(U,$J,358.3,45776,1,4,0)
- +32 ;;=4^Z51.81
- +33 ;;^UTILITY(U,$J,358.3,45776,2)
- +34 ;;=^5063064
- +35 ;;^UTILITY(U,$J,358.3,45777,0)
- +36 ;;=Z79.01^^172^2282^6
- +37 ;;^UTILITY(U,$J,358.3,45777,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,45777,1,3,0)
- +40 ;;=3^Long Term Current Use of Anticoagulants
- +41 ;;^UTILITY(U,$J,358.3,45777,1,4,0)
- +42 ;;=4^Z79.01
- +43 ;;^UTILITY(U,$J,358.3,45777,2)
- +44 ;;=^5063330
- +45 ;;^UTILITY(U,$J,358.3,45778,0)
- +46 ;;=Z79.02^^172^2282^7
- +47 ;;^UTILITY(U,$J,358.3,45778,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,45778,1,3,0)
- +50 ;;=3^Long Term Current Use of Antithrombotics/Antiplatelets
- +51 ;;^UTILITY(U,$J,358.3,45778,1,4,0)
- +52 ;;=4^Z79.02
- +53 ;;^UTILITY(U,$J,358.3,45778,2)
- +54 ;;=^5063331
- +55 ;;^UTILITY(U,$J,358.3,45779,0)
- +56 ;;=Z79.1^^172^2282^10
- +57 ;;^UTILITY(U,$J,358.3,45779,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,45779,1,3,0)
- +60 ;;=3^Long Term Current Use of NSAIDs
- +61 ;;^UTILITY(U,$J,358.3,45779,1,4,0)
- +62 ;;=4^Z79.1
- +63 ;;^UTILITY(U,$J,358.3,45779,2)
- +64 ;;=^5063332
- +65 ;;^UTILITY(U,$J,358.3,45780,0)
- +66 ;;=Z79.2^^172^2282^5
- +67 ;;^UTILITY(U,$J,358.3,45780,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,45780,1,3,0)
- +70 ;;=3^Long Term Current Use of Antibiotics
- +71 ;;^UTILITY(U,$J,358.3,45780,1,4,0)
- +72 ;;=4^Z79.2
- +73 ;;^UTILITY(U,$J,358.3,45780,2)
- +74 ;;=^321546
- +75 ;;^UTILITY(U,$J,358.3,45781,0)
- +76 ;;=Z79.82^^172^2282^8
- +77 ;;^UTILITY(U,$J,358.3,45781,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,45781,1,3,0)
- +80 ;;=3^Long Term Current Use of Aspirin
- +81 ;;^UTILITY(U,$J,358.3,45781,1,4,0)
- +82 ;;=4^Z79.82
- +83 ;;^UTILITY(U,$J,358.3,45781,2)
- +84 ;;=^5063340
- +85 ;;^UTILITY(U,$J,358.3,45782,0)
- +86 ;;=Z79.51^^172^2282^9
- +87 ;;^UTILITY(U,$J,358.3,45782,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,45782,1,3,0)
- +90 ;;=3^Long Term Current Use of Inhaled Steroids
- +91 ;;^UTILITY(U,$J,358.3,45782,1,4,0)
- +92 ;;=4^Z79.51
- +93 ;;^UTILITY(U,$J,358.3,45782,2)
- +94 ;;=^5063335
- +95 ;;^UTILITY(U,$J,358.3,45783,0)
- +96 ;;=Z79.52^^172^2282^11
- +97 ;;^UTILITY(U,$J,358.3,45783,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,45783,1,3,0)
- +100 ;;=3^Long Term Current Use of Systemic Steroids
- +101 ;;^UTILITY(U,$J,358.3,45783,1,4,0)
- +102 ;;=4^Z79.52
- +103 ;;^UTILITY(U,$J,358.3,45783,2)
- +104 ;;=^5063336
- +105 ;;^UTILITY(U,$J,358.3,45784,0)
- +106 ;;=Z91.19^^172^2282^12
- +107 ;;^UTILITY(U,$J,358.3,45784,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,45784,1,3,0)
- +110 ;;=3^Non-Compliance w/ Treatment/Regimen
- +111 ;;^UTILITY(U,$J,358.3,45784,1,4,0)
- +112 ;;=4^Z91.19
- +113 ;;^UTILITY(U,$J,358.3,45784,2)
- +114 ;;=^5063618
- +115 ;;^UTILITY(U,$J,358.3,45785,0)
- +116 ;;=Z87.01^^172^2282^15
- +117 ;;^UTILITY(U,$J,358.3,45785,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,45785,1,3,0)
- +120 ;;=3^Personal Hx of Pneumonia,Recurrent
